Citi Starts Coherus Biosciences (CHRS) at Buy, 'Come for the Biosimilars, Stay for the I/O Pipeline'
-
Coherus BioSciences (CHRS) Mentioned Positive at Citi
-
Pre-Open Stock Movers 04/08: (CHRS) (NBEV) (SNAP) Higher; (ROKU) (GE) (BA) Lower (more...)
-
Pre-Open Stock Movers 7/18: (CHRS) (FNKO) (GWW) Higher; (SAH) (WIN) (HCSG) Lower (more...)
-
Coherus BioSciences (CHRS) Prices 5.17M Share Common Offering at $14.50/Sh
-
Coherus Prices Public Offering of Common Stock
-
Coherus BioSciences (CHRS) Commences $75M Offering of Common Stock
-
Coherus Announces Proposed Public Offering of Common Stock
-
Coherus Biosciences (CHRS) PT Raised to $25 at Citi Following 4Q and FDA Meeting
-
Coherus Biosciences (CHRS) PT Raised to $25 at Citi
-
Coherus Biosciences (CHRS) PT Lowered to $33 at Citi
-
Coherus BioSciences (CHRS): Partnership Likely in 2H’17 - Citi
-
Coherus BioSciences (CHRS) Prices 5.15M Shares at $24.25
-
Coherus Prices Public Offering of Common Stock
-
Coherus BioSciences (CHRS) Commences $125M Offering of Common Stock
-
Coherus Announces Proposed Public Offering of Common Stock
-
Coherus BioSciences (CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg
-
Notable Analyst Rating Changes 7/27: (CHK) (AXTA) (SPWR) Upgraded; (TERP) (CLGX) (DEPO) Downgraded
-
Citi Starts Coherus Biosciences (CHRS) at Buy
-
Pre-Open Stock Movers 10/02: (CAMP) (WYNN) (MU) Higher; (FOLD) (PRGS) (VRX) Lower (more...)
-
After Hours Stocks Movers 10/01: (BEBE) (MU) (CAMP) Higher; (PRGS) (GMCR) (O) (more...)
-
Cooperman's Omega Shows New Express Scripts (ESRX), McDermott (MDR) Stakes; Boosts AIG (AIG), Sirius XM (SIRI); Cuts Citi (C)
-
Notable ETF Movers of the Day 12/01: (UNG) (FXI) (XRT) Higher; (USO) (XLF) (XME) Lower
-
Cooperman's Omega Advisors Shows Lower Tech Exposure, Raises Bet on Consumer Electronic Sales
-
Clough Capital Buys More Citigroup (C), Opens Petrohawk Energy (HK) Position and Lowers Cisco (CSCO)
-
Cooperman's Omega Advisors Shows New Stakes In BofA (BAC) and Verizon (VZ)

